Clinical Trial Detail

NCT ID NCT01324479
Title Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

Advanced Solid Tumor

Therapies

Capmatinib

Age Groups: adult

No variant requirements are available.